S&P 500
(0.03%) 5 249.87 points
Dow J
(0.00%) 39 759 points
Nasdaq
(-0.17%) 16 372 points
Oil
(1.72%) $82.75
Gas
(1.63%) $1.746
Gold
(1.23%) $2 239.90
Silver
(0.65%) $24.91
Platinum
(1.13%) $919.95
USD/EUR
(0.29%) $0.926
USD/NOK
(0.75%) $10.85
USD/GBP
(0.09%) $0.792
USD/RUB
(0.15%) $92.58

Realtime updates for Vincerx Pharma, Inc. [VINC]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 13:28

-14.43% $ 5.19

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 13:28):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States...

Stats
Today's Volume 335 779
Average Volume 1.09M
Market Cap 110.97M
EPS $0 ( 2024-03-26 )
Next earnings date ( $0 ) 2024-05-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -2.25
ATR14 $0.0380 (0.73%)
Insider Trading
Date Person Action Amount type
2024-03-07 Izumi Raquel E. Buy 123 750 Stock Option (right to buy)
2024-03-07 Seelenberger Alexander A. Buy 93 750 Stock Option (right to buy)
2024-03-07 Hamdy Ahmed Md Buy 146 746 Stock Option (right to buy)
2024-03-07 Thomas Tom C Buy 93 750 Stock Option (right to buy)
2023-08-11 Seelenberger Alexander A. Buy 10 500 Common Stock
INSIDER POWER
100.00
Last 97 transactions
Buy: 7 261 732 | Sell: 1 766 942

Volume Correlation

Long: -0.19 (neutral)
Short: -0.97 (very strong negative)
Signal:(43.928) Neutral

Vincerx Pharma, Inc. Correlation

10 Most Positive Correlations
SVAC0.929
PAIC0.909
RMRM0.901
TLGT0.894
MTSL0.893
SVOK0.862
MODV0.861
CLMT0.858
BOXL0.842
ABNB0.839
10 Most Negative Correlations
AMRB-0.955
NETE-0.938
MMAC-0.917
RAVN-0.869
SRAC-0.86
SBBP-0.859
LWAC-0.855
MGPI-0.841
BOCH-0.836
SHSP-0.808

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Vincerx Pharma, Inc. Correlation - Currency/Commodity

The country flag 0.02
( neutral )
The country flag 0.11
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.43
( neutral )
The country flag -0.57
( weak negative )

Vincerx Pharma, Inc. Financials

Annual 2022
Revenue: $0
Gross Profit: $-939 000 (0.00 %)
EPS: $-2.72
Q3 2023
Revenue: $0
Gross Profit: $-254 000 (0.00 %)
EPS: $-0.460
Q2 2023
Revenue: $0
Gross Profit: $-249 000 (0.00 %)
EPS: $-0.520
Q1 2023
Revenue: $0
Gross Profit: $-154 000 (0.00 %)
EPS: $-0.640

Financial Reports:

No articles found.

Vincerx Pharma, Inc.

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candidates include VIP217, an oral PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate to treat solid tumors; and VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators